Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer

被引：0
|
作者：
Torhild Veen
Arezo Kanani
Dordi Lea
Kjetil Søreide
机构：
[1] Stavanger University Hospital,Department of Gastrointestinal Surgery
[2] Stavanger University Hospital,Gastrointestinal Translational Research Unit, Laboratory for Molecular Medicine
[3] Stavanger University Hospital,Department of Pathology
[4] University of Bergen,Department of Clinical Medicine
来源：
Cancer Immunology, Immunotherapy | 2023年 / 72卷
关键词：
Immunotherapy; Immune checkpoint inhibitor; Mismatch repair deficiency; Colon cancer; Rectal cancer; Study design;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3135 / 3147
页数：12
相关论文
共 50 条
  • [41] Classification of early-stage colon cancer with Immunoscore®: clinical evidence and case studies
    Yalcin, Suayib
    Philip, Philip A.
    Athanasiadis, Ilias
    Bazarbashi, Shouki
    Shamseddine, Ali
    FUTURE ONCOLOGY, 2022, 18 (05) : 613 - 623
  • [42] Neoadjuvant immune checkpoint inhibitors in high-risk stage III melanoma
    Ferraresi, Virginia
    Vari, Sabrina
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (03)
  • [43] Patient perspectives on window of opportunity clinical trials in early-stage breast cancer
    Parikh, Divya A.
    Kody, Lisa
    Brain, Susie
    Heditsian, Diane
    Lee, Vivian
    Curtis, Christina
    Karin, Mardi R.
    Wapnir, Irene L.
    Patel, Manali, I
    Sledge, George W., Jr.
    Caswell-Jin, Jennifer L.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (01) : 171 - 178
  • [44] Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer
    Campbell, Michael J.
    Wolf, Denise M.
    Yau, Christina
    Brown-Swigart, Lamorna
    Wulfkuhle, Julie
    Gallagher, Isela R.
    Zhu, Zelos
    Bolen, Jennifer
    Vandenberg, Scott
    Hoyt, Clifford
    Mori, Hidetoshi
    Borowsky, Alexander
    Sit, Laura
    Perlmutter, Jane
    Asare, Smita M.
    Nanda, Rita
    Liu, Minetta C.
    Yee, Douglas
    Demichele, Angela M.
    Hylton, Nola M.
    Pusztai, Lajos
    Berry, Donald A.
    Hirst, Gillian L.
    Petricoin, Emanuel F.
    van't Veer, Laura
    Esserman, Laura
    CELL REPORTS MEDICINE, 2024, 5 (11)
  • [45] Patient perspectives on window of opportunity clinical trials in early-stage breast cancer
    Divya A. Parikh
    Lisa Kody
    Susie Brain
    Diane Heditsian
    Vivian Lee
    Christina Curtis
    Mardi R. Karin
    Irene L. Wapnir
    Manali I. Patel
    George W. Sledge
    Jennifer L. Caswell-Jin
    Breast Cancer Research and Treatment, 2022, 194 : 171 - 178
  • [46] The Effectiveness of Immune Checkpoint Inhibitors in the Neoadjuvant and Post-Neoadjuvant Breast Cancer Settings
    Pusztai, Lajos
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (09) : 552 - 555
  • [47] CHEMOTHERAPY Failure of bevacizumab in early-stage colon cancer
    Sargent, Daniel J.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (01) : 10 - 11
  • [48] Lymph node evaluation in early-stage colon cancer
    Govindarajan, Arland
    Baxter, Nancy N.
    CLINICAL COLORECTAL CANCER, 2008, 7 (04) : 240 - 246
  • [49] Research progress on immune checkpoint inhibitors in neoadjuvant therapy for gastric cancer
    Wenting Li
    Shiying Yu
    Oncology and Translational Medicine, 2022, 8 (02) : 74 - 82
  • [50] RNA Interference Advances to Early-Stage Clinical Trials
    Brower, Vicki
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (19) : 1459 - 1461
12345